161 related articles for article (PubMed ID: 28798015)
21. Major complications and mortality within 30 days of an electrophysiological procedure at an academic medical center: implications for developing national standards.
Hussain SK; Eddy MM; Moorman L; Malhotra R; Darby AE; Bilchick K; Mason P; Mangrum MJ; Dimarco JP; Ferguson JD
J Cardiovasc Electrophysiol; 2015 May; 26(5):527-31. PubMed ID: 25684120
[TBL] [Abstract][Full Text] [Related]
22. Transcatheter aortic valve replacement program development: recommendations for best practice.
Hawkey MC; Lauck SB; Perpetua EM; Fowler J; Schnell S; Speight M; Lisby KH; Webb JG; Leon MB
Catheter Cardiovasc Interv; 2014 Nov; 84(6):859-67. PubMed ID: 24760495
[TBL] [Abstract][Full Text] [Related]
23. Impact of access to hospitals with catheterization facilities in the second Gulf Registry of Acute Coronary Events (Gulf RACE-2).
Alhabib KF; Jolly SS; Yusuf S; Alsheikh-Ali AA; Al Suwaidi J; Hersi A; Sulaiman K; Al Saif S; Almahmeed W; Asaad N; Amin H; Al-Motarreb A; Alfaleh H; Alnemer K; Thalib L
Coron Artery Dis; 2013 Aug; 24(5):412-8. PubMed ID: 23652362
[TBL] [Abstract][Full Text] [Related]
24. Primary percutaneous coronary intervention without on-site cardiac surgery backup in unselected patients with ST-segment-elevation myocardial infarction: the Rivoli ST-segment elevation myocardial infarction (RISTEMI) registry.
Tomassini F; Gagnor A; Montali N; Infantino V; Tizzani E; Tizzani P; Lanza GA; Conte MR; Varbella F
Cardiovasc Revasc Med; 2013; 14(1):9-13. PubMed ID: 23337379
[TBL] [Abstract][Full Text] [Related]
25. PCI Choice Decision Aid for Stable Coronary Artery Disease: A Randomized Trial.
Coylewright M; Dick S; Zmolek B; Askelin J; Hawkins E; Branda M; Inselman JW; Zeballos-Palacios C; Shah ND; Hess EP; LeBlanc A; Montori VM; Ting HH
Circ Cardiovasc Qual Outcomes; 2016 Nov; 9(6):767-776. PubMed ID: 27803090
[TBL] [Abstract][Full Text] [Related]
26. Clinical expert consensus statement on best practices in the cardiac catheterization laboratory: Society for Cardiovascular Angiography and Interventions.
Naidu SS; Rao SV; Blankenship J; Cavendish JJ; Farah T; Moussa I; Rihal CS; Srinivas VS; Yakubov SJ;
Catheter Cardiovasc Interv; 2012 Sep; 80(3):456-64. PubMed ID: 22434598
[No Abstract] [Full Text] [Related]
27. Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: validation of the logistic clinical SYNTAX (Synergy Between Percutaneous Coronary Interventions With Taxus and Cardiac Surgery) score.
Farooq V; Vergouwe Y; Généreux P; Bourantas CV; Palmerini T; Caixeta A; Garcìa-Garcìa HM; Diletti R; Morel MA; McAndrew TC; Kappetein AP; Valgimigli M; Windecker S; Dawkins KD; Steyerberg EW; Serruys PW; Stone GW
JACC Cardiovasc Interv; 2013 Jul; 6(7):737-45. PubMed ID: 23866185
[TBL] [Abstract][Full Text] [Related]
28. Hospital Performance on Percutaneous Coronary Intervention Process and Outcomes Measures.
Chui PW; Parzynski CS; Nallamothu BK; Masoudi FA; Krumholz HM; Curtis JP
J Am Heart Assoc; 2017 Apr; 6(5):. PubMed ID: 28446493
[TBL] [Abstract][Full Text] [Related]
29. Assessment of Operator Variability in Risk-Standardized Mortality Following Percutaneous Coronary Intervention: A Report From the NCDR.
Doll JA; Dai D; Roe MT; Messenger JC; Sherwood MW; Prasad A; Mahmud E; Rumsfeld JS; Wang TY; Peterson ED; Rao SV
JACC Cardiovasc Interv; 2017 Apr; 10(7):672-682. PubMed ID: 28385404
[TBL] [Abstract][Full Text] [Related]
30. Outcomes of cardiac catheterization and percutaneous coronary intervention for in-hospital ventricular tachycardia or fibrillation cardiac arrest.
Helton TJ; Nadig V; Subramanya SD; Menon V; Ellis SG; Shishehbor MH
Catheter Cardiovasc Interv; 2012 Aug; 80(2):E9-14. PubMed ID: 21735517
[TBL] [Abstract][Full Text] [Related]
31. Mortality Is Not an Adequate Surrogate for Percutaneous Coronary Intervention Quality.
King SB
JACC Cardiovasc Interv; 2016 Feb; 9(4):397-398. PubMed ID: 26892091
[No Abstract] [Full Text] [Related]
32. Transradial versus transfemoral percutaneous coronary intervention in acute coronary syndromes: re-evaluation of the current body of evidence.
Lee MS; Wolfe M; Stone GW
JACC Cardiovasc Interv; 2013 Nov; 6(11):1149-52. PubMed ID: 24262614
[TBL] [Abstract][Full Text] [Related]
33. Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.
Sotomi Y; Cavalcante R; van Klaveren D; Ahn JM; Lee CW; de Winter RJ; Wykrzykowska JJ; Onuma Y; Steyerberg EW; Park SJ; Serruys PW
JACC Cardiovasc Interv; 2016 Aug; 9(15):1564-72. PubMed ID: 27491605
[TBL] [Abstract][Full Text] [Related]
34. Impact of lean six sigma process improvement methodology on cardiac catheterization laboratory efficiency.
Agarwal S; Gallo JJ; Parashar A; Agarwal KK; Ellis SG; Khot UN; Spooner R; Murat Tuzcu E; Kapadia SR
Cardiovasc Revasc Med; 2016 Mar; 17(2):95-101. PubMed ID: 26905051
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
36. Interventional cardiac catheterization predictors at Al-Arabi heart Center in Palestine in 2017.
Alkaiyat A; Abumadi R; Atari S; Sayeh W; Al Zabadi H; Sarawan Z; Bisharat F; Shakhshir N
BMC Cardiovasc Disord; 2019 Oct; 19(1):237. PubMed ID: 31660865
[TBL] [Abstract][Full Text] [Related]
37. Comparative effectiveness and safety of a catheterization laboratory-only eptifibatide dosing strategy in patients undergoing percutaneous coronary intervention.
Gurm HS; Hosman C; Bates ER; Share D; Hansen BB;
Circ Cardiovasc Interv; 2015 Feb; 8(2):e001880. PubMed ID: 25657314
[TBL] [Abstract][Full Text] [Related]
38. Relationship Between Femoral Vascular Closure Devices and Short-Term Mortality From 271 845 Percutaneous Coronary Intervention Procedures Performed in the United Kingdom Between 2006 and 2011: A Propensity Score-Corrected Analysis From the British Cardiovascular Intervention Society.
Farooq V; Goedhart D; Ludman P; de Belder MA; Harcombe A; El-Omar M;
Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27225421
[TBL] [Abstract][Full Text] [Related]
39. Appropriateness and Outcomes of Percutaneous Coronary Intervention at Top-Ranked and Nonranked Hospitals in the United States.
Sukul D; Bhatt DL; Seth M; Zakroysky P; Wojdyla D; Rumsfeld JS; Wang T; Rao SV; Gurm HS
JACC Cardiovasc Interv; 2018 Feb; 11(4):342-350. PubMed ID: 29471947
[TBL] [Abstract][Full Text] [Related]
40. Role of cardiac catheterization and percutaneous coronary intervention in the preoperative assessment and management of patients before orthotopic liver transplantation.
Maddur H; Bourdillon PD; Liangpunsakul S; Joseph Tector A; Fridell JA; Ghabril M; Lacerda MA; Bourdillon C; Shen C; Kwo PY
Liver Transpl; 2014 Jun; 20(6):664-72. PubMed ID: 24648247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
